<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Galt from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Galt news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 00:35:06 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Galt" rel="self" type="application/rss+xml" />

	
<item><title>McDonald's Returns 20% Since Added to Galtstock Long-Term Portfol...</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015237&amp;HITNO=0&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015237&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524339093%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015237&amp;HITNO=0&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015237&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524339093%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Zibb:</description></item>
<item><title>McDonald's Returns 20% Since Added to Galtstock Long-Term Portfolio</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015059&amp;HITNO=1&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015059&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524251912%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015059&amp;HITNO=1&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015059&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524251912%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>TradingMarkets:</description></item>
<item><title>Skilled workers needed to replace baby boomers</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3953426&amp;HITNO=2&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3953426&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2491590264%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3953426&amp;HITNO=2&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3953426&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2491590264%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Research &amp; Development:</description></item>
<item><title>Good Early Results for Sangamo's HIV Drug</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3941794&amp;HITNO=3&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3941794&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2485580214%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3941794&amp;HITNO=3&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3941794&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2485580214%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmaceutical Technology:</description></item>
<item><title>Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 1 Safety Trial of ...</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3939089&amp;HITNO=4&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3939089&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2484405944%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3939089&amp;HITNO=4&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3939089&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2484405944%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PipelineReview:</description></item>
<item><title>Preliminary data from Phase 1 study of Sangamo BioSciences' SB-728-T announced</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3932912&amp;HITNO=5&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3932912&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481408564%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3932912&amp;HITNO=5&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3932912&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481408564%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>Sangamo BioSciences Announces Presentation Of Preliminary Data From Phase 1 Safety Trial Of SB-728-T For HIV/A</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3933952&amp;HITNO=6&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3933952&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481989558%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3933952&amp;HITNO=6&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3933952&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481989558%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Medical News Today:</description></item>
<item><title>Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 1 Safety Trial of SB-728-T for HIV/AIDS: First Human Data from ZFN Clinical Program (AEGiS)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3933262&amp;HITNO=7&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3933262&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481592310%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3933262&amp;HITNO=7&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3933262&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481592310%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>AEGIS:</description></item>
<item><title>Sangamo BioSciences (SGMO) Announces Preliminary SB-728-T Phase I Data</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928123&amp;HITNO=8&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928123&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479135312%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928123&amp;HITNO=8&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928123&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479135312%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 1 Safety Trial of SB-728-T for HIV/AIDS / First Human Data from ZFN Clinical Program ZFN-Modified Cells Well Tolerated and Able to Expand</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3927811&amp;HITNO=9&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3927811&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479040809%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3927811&amp;HITNO=9&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3927811&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479040809%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FinanzNachrichten.de:</description></item>
<item><title>Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 1 Safety Trial of SB-728-T for HIV/A</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3929214&amp;HITNO=10&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3929214&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479509821%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3929214&amp;HITNO=10&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3929214&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479509821%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 1 Safety Trial of SB-728-T for HIV/A</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928867&amp;HITNO=11&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928867&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479367368%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928867&amp;HITNO=11&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928867&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479367368%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 1 Safety Trial of SB-728-T for HIV/AIDS</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928523&amp;HITNO=12&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928523&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479243605%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928523&amp;HITNO=12&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928523&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479243605%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Birmingham Business Journal:</description></item>
<item><title>Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 1 Safety Trial of SB-728-T for HIV/AIDS</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928495&amp;HITNO=13&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928495&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479238049%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928495&amp;HITNO=13&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928495&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479238049%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pittsburgh Business Times:</description></item>
<item><title>Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 1 Safety Trial of SB-728-T for HIV/AIDS</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928448&amp;HITNO=14&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928448&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479229700%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928448&amp;HITNO=14&amp;MSIZE=44&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Galt&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928448&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479229700%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Phoenix Business Journal:</description></item>
</channel></rss>